In late September and early October 2026, Travere Therapeutics reported new FILSPARI® (sparsentan) data across IgA ...

(Nasdaq: TVTX) today announced that it will share nine new data presentations, including five oral presentations, at the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie and Alkermes . AbbVie (ABBV) In a report released yesterday, Vamil Divan fr ...

The pair will work together to progress lixudebart across multiple rare kidney and liver diseases.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Pharmaceutical & Biotech Stock Introductory Series, Part 2, Episode 1 / 12 Episodes Total]IntroductionLigand Pharmaceuticals ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.

Quince Therapeutics, Inc. announced that Effective as of October 8, 2026, John Militello, CPA, was appointed as Chief Financial Officer of the Company. John Militello, CPA, age 53, has served as Head ...

Join Us at the Blue Hope Bash to Support the Fight Against Colorectal Cancer / Blue Hope Bash Committee, cancer, colorectal ...

Guggenheimanalyst Vamil Divan maintains $Travere Therapeutic(TVTX.US)$ with a buy rating, and maintains the target price at ...

Accordingto Bank of America Securities' initial coverage report, AP301's revenue in the Chinese market could reach ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...